Literature DB >> 2272765

Automated measurement of transplantable solid tumors using digital electronic calipers interfaced to a microcomputer.

J F Worzalla1, J R Bewley, G B Grindey.   

Abstract

Data collection for transplantable solid tumors has been automated with electronic digital calipers and a balance which have been coupled through an RS-232 interface to a microcomputer. BASIC programs handle data entry, calculations and data storage. A "PROTOCOL" program accepts keyboard input of sample name, notebook number, submitter and dose along with necessary information on tumor system, and then initial animal weights for treatment groups are sent from balance to computer. Data is stored as an ASCII file on floppy disks, and protocol reports are printed. When the test is to be measured, a "MEASURE" program prompts the user for keyboard entry of toxic deaths in each group. Then the computer requests input of width and length of tumors for each animal. These tumor dimensions are sent to microcomputer by pressing a button on the calipers. When a group is completed, final animal weights are sent from balance to microcomputer. Then tumor weights and percent inhibition as compared to appropriate control groups are calculated, and the data is appended to the file for that test. A hard copy is generated as tumors are measured, and reports including percent inhibition can be printed immediately after a test is measured. The data as an ASCII file is transferred via modem to mainframe computer, where another program transfers the information to a database management program. These automated procedures for tumor measurement save time and lessen the chance for error by eliminating manual recording of solid tumor dimensions and subsequent reentry of this data for calculation.

Entities:  

Mesh:

Year:  1990        PMID: 2272765     DOI: 10.1007/bf00171833

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  9 in total

1.  Growth rate of human tumour xenografts measured in nude mice by in vivo cast modelling.

Authors:  A G Fiennes
Journal:  Br J Surg       Date:  1988-01       Impact factor: 6.939

2.  Metastatic incidence of a spontaneous murine mammary adenocarcinoma.

Authors:  J C Anderson; R A Fugmann; R L Stolfi; D S Martin
Journal:  Cancer Res       Date:  1974-08       Impact factor: 12.701

3.  Combinations of mesna with cyclophosphamide or adriamycin in the treatment of mice with tumors.

Authors:  R J Bernacki; S K Bansal; H L Gurtoo
Journal:  Cancer Res       Date:  1987-02-01       Impact factor: 12.701

4.  A new digital electronic caliper for measurement of coronary arterial stenosis: comparison with visual estimates and computer-assisted measurements.

Authors:  D P Scoblionko; B G Brown; S Mitten; J H Caldwell; J W Kennedy; E L Bolson; H T Dodge
Journal:  Am J Cardiol       Date:  1984-03-01       Impact factor: 2.778

5.  Determinants of intrinsic sensitivity to Vinca alkaloids in xenografts of pediatric rhabdomyosarcomas.

Authors:  J A Houghton; L G Williams; P M Torrance; P J Houghton
Journal:  Cancer Res       Date:  1984-02       Impact factor: 12.701

6.  Arabinofuranosyl-5-azacytosine: antitumor and cytotoxic properties.

Authors:  M Dalal; J Plowman; T R Breitman; H M Schuller; A A del Campo; D T Vistica; J S Driscoll; D A Cooney; D G Johns
Journal:  Cancer Res       Date:  1986-02       Impact factor: 12.701

7.  Estimation of liver tumor volume using different formulas - an experimental study in rats.

Authors:  G Carlsson; B Gullberg; L Hafström
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

8.  Tumor measurement in the nude mouse.

Authors:  D M Euhus; C Hudd; M C LaRegina; F E Johnson
Journal:  J Surg Oncol       Date:  1986-04       Impact factor: 3.454

9.  Growth of human colonic adenocarcinoma and development of serum CEA in in athymic mice. I: Strict correlation of tumour size and mass with serum CEA concentration during logarithmic growth.

Authors:  H J Staab; F A Anderer
Journal:  Br J Cancer       Date:  1982-12       Impact factor: 7.640

  9 in total
  3 in total

1.  Biochemistry and pharmacology of glycinamide ribonucleotide formyltransferase inhibitors: LY309887 and lometrexol.

Authors:  L G Mendelsohn; C Shih; R M Schultz; J F Worzalla
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

2.  Comparison of the antitumor activity of gemcitabine and ara-C in a panel of human breast, colon, lung and pancreatic xenograft models.

Authors:  R L Merriman; L W Hertel; R M Schultz; P J Houghton; J A Houghton; P G Rutherford; L R Tanzer; G B Boder; G B Grindey
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

3.  MT95-4, a fully humanized antibody raised against aminopeptidase N, reduces tumor progression in a mouse model.

Authors:  Shin Akita; Noboru Hattori; Takeshi Masuda; Yasushi Horimasu; Taku Nakashima; Hiroshi Iwamoto; Kazunori Fujitaka; Masayuki Miyake; Nobuoki Kohno
Journal:  Cancer Sci       Date:  2015-05-29       Impact factor: 6.716

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.